Particularly, ENY2 was closely associated with early recurrence but was weakly correlated with late recurrence (Figure S1), suggesting that ENY2 might predict the early recurrence of HCC better than late recurrence. This evidence concerns the gene ENY2 and hepatocellular carcinoma.